Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
6(67%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
11%
Ph phase_2
3
33%
Ph phase_3
5
56%

Phase Distribution

1

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
3(33.3%)
Phase 3Large-scale testing
5(55.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

6

trials recruiting

Total Trials

9

all time

Status Distribution
Active(7)
Completed(2)

Detailed Status

Recruiting6
Completed2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
6
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (11.1%)
Phase 23 (33.3%)
Phase 35 (55.6%)

Trials by Status

recruiting667%
completed222%
not_yet_recruiting111%

Recent Activity

6 active trials
Showing 5 of 9
not_yet_recruitingphase_2

A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease

NCT07403968
completedphase_3

A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis

NCT06973291
recruitingphase_2

A Study of Zasocitinib in Adults With Nonsegmental Vitiligo

NCT07108283
recruitingphase_3

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

NCT07286058
recruitingphase_3

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

NCT06671483
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07403968Phase 2

A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease

Not Yet Recruiting
NCT06973291Phase 3

A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis

Completed
NCT07108283Phase 2

A Study of Zasocitinib in Adults With Nonsegmental Vitiligo

Recruiting
NCT07286058Phase 3

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

Recruiting
NCT06671483Phase 3

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

Recruiting
NCT06671496Phase 3

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

Recruiting
NCT07250802Phase 3

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

Recruiting
NCT06764615Phase 2

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

Recruiting
NCT06793943Phase 1

A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9